Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Huma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Huma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Huma Today - Breaking & Trending Today

Humacyte (NASDAQ:HUMA) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS - Vimarsana News

Humacyte (NASDAQ:HUMA) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Humacyte (NASDAQ:HUMA – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.01, Yahoo Finance reports. During the same quarter last year, the company posted ($0.21) earnings per share. Humacyte Stock Down 8.1 % Shares of NASDAQ […]

Humacyte (NASDAQ:HUMA) Announces Earnings Results, Beats Estimates By $0.01 EPS - Vimarsana News

Humacyte (NASDAQ:HUMA) Announces Earnings Results, Beats Estimates By $0.01 EPS

Humacyte (NASDAQ:HUMA – Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.01, Yahoo Finance reports. During the same period last year, the firm posted ($0.21) earnings per share. Humacyte Price Performance Shares of Humacyte stock opened […]

Humacyte (NASDAQ:HUMA) Issues Earnings Results, Beats Estimates By $0.01 EPS - Vimarsana News

Humacyte (NASDAQ:HUMA) Issues Earnings Results, Beats Estimates By $0.01 EPS

Humacyte (NASDAQ:HUMA – Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.24) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.01, Yahoo Finance reports. During the same period in the previous year, the business posted ($0.21) EPS. Humacyte Trading Down 8.1 % Shares of HUMA […]

Source: wkrb13.com
Humacyte, Inc. Announces Pricing of $40.2 Million Public - Vimarsana News

Humacyte, Inc. Announces Pricing of $40.2 Million Public

DURHAM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally...

Hamilton Lane Advisors LLC Cuts Holdings in Humacyte, Inc. (NASDAQ:HUMA) - Vimarsana News

Hamilton Lane Advisors LLC Cuts Holdings in Humacyte, Inc. (NASDAQ:HUMA)

Hamilton Lane Advisors LLC trimmed its holdings in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 58.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,893 shares of the company’s stock after selling 30,800 shares during the period. Humacyte […]